Researchers compared treatment with tocilizumab vs rituximab in patients with rheumatoid arthritis with an inadequate response to anti-TNF therapy.
Researchers evaluated the role of machine learning in predicting response before anti-tumor necrosis factor treatment in rheumatoid arthritis.
Researchers evaluated the effectiveness of tumor necrosis factor (TNF) vs non-TNF inhibitors in the treatment of rheumatoid arthritis.
Researchers developed a molecular test that predicts inadequate response to anti-TNF therapies in biologic-naive patients with rheumatoid arthritis.
Researchers evaluated the long-term treatment with tumor necrosis factor inhibitors on radiographic progression in patients with ankylosing spondylitis.
Researchers evaluated the frequency and severity of pain and fatigue in patients with psoriatic arthritis receiving tumor necrosis factor inhibitors.
Researchers investigated the treatment response of patients receiving tumor necrosis factor inhibitors in the real-world vs clinical trials.
A subset of patients at risk for Alzheimer disease because of systemic inflammation may benefit from receiving a tumor necrosis factor (TNF) blocking agent.
Researchers compared the effectiveness of tumor necrosis factor inhibitor combination therapy vs monotherapy in psoriatic arthritis.
Researchers determined the adherence to subcutaneous antitumor necrosis factor agents in rheumatoid arthritis, and evaluated the influence of injection site pain and skin perceptions on treatment adherence.
